Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

Kalincik T., Jokubaitis V., IZQUIERDO G., DUQUETTE P., GIRARD M., Grammond P., ...More

MULTIPLE SCLEROSIS JOURNAL, vol.21, no.9, pp.1159-1171, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 21 Issue: 9
  • Publication Date: 2015
  • Doi Number: 10.1177/1352458514559865
  • Journal Name: MULTIPLE SCLEROSIS JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1159-1171
  • Keywords: Multiple sclerosis, treatment outcomes, patient registry, real-world date, propensity score, relapses, disability, MULTICENTER, REBIF, BIAS
  • Karadeniz Technical University Affiliated: Yes

Abstract

Background: The results of head-to-head comparisons of injectable immunomodulators (interferon , glatiramer acetate) have been inconclusive and a comprehensive analysis of their effectiveness is needed.